V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330003561 | 330001824 | 1.74 | 83 | Palliative (P) | 2016-10-31 | 2016-11-13 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 330013154 | CISPLATIN + GEMCITABINE |
| 330003562 | 330001824 | 1.7 | 90.5 | Palliative (P) | 2014-08-19 | 2014-08-24 | CISPLATIN + GEMCITABINE | N | N | 330013154 | CISPLATIN + GEMCITABINE |
| 330003563 | 330001825 | 0 | 51.3 | Palliative (P) | 2018-10-02 | 2018-10-22 | Cyclophosphamide + Dex + Rituximab | 02 | N | 330013163 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330003564 | 330006982 | 1.56 | 64 | Adjuvant (A) | 2015-07-08 | 2015-07-08 | Cisplatin + Gemcitabine (D 1 & 8) | Y | N | 330013164 | CISPLATIN + GEMCITABINE |
| 330003565 | 330006982 | 1.72 | 58 | null | null | 2014-02-06 | Cetuximab + Radiotherapy Load | null | null | 330013164 | CETUXIMAB + RT |
| 330003566 | 330006982 | 1.69 | 66.2 | Curative (C) | 2015-12-19 | 2015-12-25 | GemCarbo Days 1+8 | N | N | 330013164 | GEMCARBO |
| 330003567 | 330006982 | null | 131 | Neo-adjuvant (N) | 2016-02-15 | 2016-02-18 | CAP | N | N | 330013164 | CAP |
| 330003568 | 330001826 | 1.77 | null | Curative (C) | 2015-10-09 | 2015-10-09 | EURAMOS TRIAL | N | N | 330013171 | EURAMOS TRIAL |
| 330003569 | 330006983 | 1.77 | 85.8 | null | 2016-09-06 | 2016-10-04 | PAM x 2 post-surgery (cycles 3&4) | N | N | 330013173 | MAP |
| 330003570 | 330006983 | 1.7 | 72.7 | Curative (C) | 2014-09-03 | 2014-09-07 | CETUXIMAB + RT | 02 | null | 330013173 | CETUXIMAB + RT |
| 330003571 | 330006983 | 0 | 67.3 | Neo-adjuvant (N) | 2014-01-04 | 2014-01-05 | OST Euramos 1 Closed Trial - AP | N | N | 330013173 | MAP |
| 330003572 | 330006983 | 0 | 82 | Curative (C) | 2014-04-05 | 2014-04-06 | CAP | N | N | 330013173 | CAP |
| 330003573 | 330006983 | 1.63 | 42.6 | Curative (C) | 2015-12-10 | 2015-12-10 | CVP R | 02 | N | 330013173 | CVP R |
| 330003574 | 330006983 | 1.77 | 78 | Palliative (P) | 2016-10-17 | 2016-10-21 | CARBOPLATIN + GEMCITABINE | N | N | 330013173 | GEMCARBO |
| 330003575 | 330001827 | 1.59 | 56.4 | Palliative (P) | 2016-02-28 | 2016-03-13 | Carbo F | N | N | 330013185 | CARBO + FLUOROURACIL |
| 330003576 | 330001827 | 1.87 | 77.4 | Curative (C) | 2015-01-12 | 2015-01-25 | DA 3 + 10 | 02 | N | 330013185 | DA |
| 330003577 | 330001827 | 1.66 | 49.5 | Palliative (P) | 2017-01-27 | 2017-02-19 | CVP R | N | N | 330013185 | CVP R |
| 330003578 | 330001827 | 1.69 | 62.2 | Palliative (P) | 2014-04-09 | 2014-12-13 | CISPLATIN + ETOPOSIDE | 02 | N | 330013185 | CISPLATIN + ETOPOSIDE |
| 330003579 | 330012179 | 1.8 | null | Curative (C) | 2014-01-27 | 2014-02-17 | CETUXIMAB + RT | N | Y | 330013194 | CETUXIMAB + RT |
| 330003580 | 330001828 | 0 | 61 | Curative (C) | 2013-02-03 | 2013-02-08 | MAP | 02 | Y | 330013199 | MAP |
| 330003581 | 330001829 | null | 109.1 | Curative (C) | 2017-10-22 | 2017-10-22 | CISPLATIN + ETOPOSIDE | N | N | 330013200 | CISPLATIN + ETOPOSIDE |
| 330003582 | 330001829 | 0 | 105 | Neo-adjuvant (N) | 2016-06-02 | 2016-06-07 | CAP | N | N | 330013200 | CAP |
| 330003583 | 330001830 | 1.78 | 77 | Curative (C) | 2017-04-12 | 2017-04-30 | CVP R | N | N | 330013204 | CVP R |
| 330003584 | 330001830 | 1.7 | 85.7 | Curative (C) | 2015-02-18 | 2015-02-24 | CARBOPLATIN + FLUOROURACIL | N | N | 330013204 | CARBO + FLUOROURACIL |
| 330003585 | 330001831 | 0 | 74.4 | Palliative (P) | 2016-04-27 | 2016-05-04 | CISPLATIN + ETOPOSIDE | Y | N | 330013210 | CISPLATIN + ETOPOSIDE |
| 330003586 | 330006987 | 1.82 | 76.7 | Neo-adjuvant (N) | 2014-05-16 | 2014-05-16 | EURAMOS TRIAL | Y | N | 330013211 | EURAMOS TRIAL |
| 330003587 | 330009770 | 1.69 | 107 | Neo-adjuvant (N) | 2017-11-09 | 2017-11-09 | Dox + HD Mtx (post PAM) | N | N | 330013215 | DOXORUBICIN + HD MTX |
| 330003588 | 330001832 | null | null | Palliative (P) | 2017-11-08 | 2017-11-15 | GemCarbo Days 1+8 | 02 | N | 330013216 | GEMCARBO |
| 330003589 | 330001833 | 1.84 | 47.2 | Adjuvant (A) | 2015-07-31 | 2015-08-16 | CAP | N | N | 330013218 | CAP |
| 330003590 | 330001834 | 0 | 61.5 | Palliative (P) | 2015-04-28 | 2015-05-09 | GemCarbo Days 1+8 | N | N | 330013219 | GEMCARBO |
| 330003591 | 330001835 | 1.79 | 82.4 | Neo-adjuvant (N) | 2017-01-27 | 2017-02-25 | Dox + HD Mtx (post PAM) | N | N | 330013222 | DOXORUBICIN + HD MTX |
| 330003592 | 330001836 | 1.78 | 47 | Not known (9) | 2013-05-11 | 2013-05-11 | CVP R | N | N | 330013223 | CVP R |
| 330003593 | 330001836 | 1.66 | 59.1 | Curative (C) | 2015-05-18 | 2015-05-18 | EW EuroEwing 2012 Arm A VIDE | N | N | 330013223 | EURO-EWING |
| 330003594 | 330009771 | 1.63 | 63.5 | Curative (C) | 2016-04-04 | 2016-04-04 | CETUXIMAB + RT | 2 | Y | 330013226 | CETUXIMAB + RT |
| 330003595 | 330009771 | null | 61 | Not known (9) | 2016-12-02 | 2016-12-24 | CISPLATIN + GEMCITABINE | null | N | 330013226 | CISPLATIN + GEMCITABINE |
| 330003596 | 330012180 | 1.73 | 84.8 | Curative (C) | null | 2015-01-26 | CETUXIMAB | N | Y | 330013229 | CETUXIMAB |
| 330003597 | 330012180 | 1.63 | 71.7 | Curative (C) | 2016-10-21 | 2016-10-21 | Carboplatin+Fluorouracil 4 or 5 day | N | null | 330013229 | CARBO + FLUOROURACIL |
| 330003598 | 330012948 | 1.64 | 59 | Palliative (P) | 2017-03-15 | 2017-03-15 | GemCarbo Days 1+8 | 02 | null | 330013232 | GEMCARBO |
| 330003599 | 330001837 | 1.78 | 72.9 | Adjuvant (A) | 2014-04-29 | 2014-06-02 | EURAMOS TRIAL | N | N | 330013233 | EURAMOS TRIAL |
| 330003600 | 330001837 | 1.78 | null | Palliative (P) | null | 2014-07-09 | Dox + HD Mtx (post PAM) | null | null | 330013233 | DOXORUBICIN + HD MTX |
| 330003601 | 330001837 | 1.6 | 64.5 | Curative (C) | 2012-10-26 | 2013-10-29 | MAP | N | N | 330013233 | MAP |
| 330003602 | 330001837 | 1.65 | 64 | Curative (C) | 2014-11-05 | 2014-11-12 | Cetuximab + Radiotherapy Maint | 2 | Y | 330013233 | CETUXIMAB + RT |
| 330003603 | 330001837 | null | 49.1 | Adjuvant (A) | 2013-10-27 | 2013-11-05 | CAP | N | N | 330013233 | CAP |
| 330003604 | 330001838 | 1.54 | 63.7 | Curative (C) | 2013-08-20 | 2013-08-20 | CETUXIMAB + RT | 02 | Y | 330013240 | CETUXIMAB + RT |
| 330003605 | 330001838 | 1.8 | 67.9 | Palliative (P) | 2014-09-24 | 2014-10-03 | CETUXIMAB | N | Y | 330013240 | CETUXIMAB |
| 330003606 | 330001838 | 1.76 | 73.5 | null | 2013-07-04 | 2013-07-11 | Carbo F | N | Y | 330013240 | CARBO + FLUOROURACIL |
| 330003607 | 330001838 | 1.57 | null | Curative (C) | 2013-11-21 | 2013-11-21 | EW EuroEwing 99 : VIDE | null | null | 330013240 | EURO-EWING |
| 330003608 | 330001838 | 1.64 | 62.5 | null | 2016-03-19 | 2016-03-19 | CETUXIMAB + RT | N | N | 330013240 | CETUXIMAB + RT |
| 330003609 | 330012660 | 1.52 | 60.2 | Disease modification (D) | 2013-04-25 | 2013-04-28 | DA 3 + 10 | 02 | N | 330013245 | DA |
| 330003610 | 330012660 | 1.78 | 83.4 | Palliative (P) | 2018-04-03 | 2018-04-10 | Cisplatin + Etoposide po&iv 3 day | null | null | 330013245 | CISPLATIN + ETOPOSIDE |